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Abstract 
BACKGROUND: Differentiation of stable angina from unstable angina is important because they need different 
approaches. Few studies have been conducted to assess the diagnostic value of high sensitive C-reactive protein 
(hs-CRP) in differentiating these two diseases. This study aimed to evaluate the diagnostic value of hs-CRP levels 
for differentiating stable angina from unstable angina.  
METHODS: After signing the consent form, patients with unstable angina who referred to Tohid Hospital emergency 
in Sanandaj, Iran, and patients with stable angina who referred to the special clinic of the hospital were evaluated. 
Disease was confirmed by a cardiologist. Morning serum hs-CRP was tested using MONOBIND laboratory kit (USA). 
Data were analyzed by SPSS using Student’s independent t-test, Mann-Whitney U, chi-square, Fisher exact test, 
and receiver operating characteristic curve. 
RESULTS: hs-CRP levels in patients with stable angina and unstable angina were 1.6 (± 1.18) and 2.35 (± 1.30) 
mg/l, respectively (P = 0.025). The hs-CRP level ≥ 2.31 mg/l was the best cut-off point for differentiating stable 
from unstable angina. At this cut-off point, the sensitivity and specificity were 56% and 73%, respectively. Area 
under the curve was calculated to be 0.679 (95% confidence interval: 0.54-0.81) (P = 0.017). 
CONCLUSION: hs-CRP level is helpful for differentiating patients with stable angina from those with unstable 
angina. It is recommended to consider the hs-CRP level of 2.31 mg/l as the best cut-off point. 
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Introduction1 
Inflammation is a common component of 
atherosclerosis and is a likely cause of rupture in 
atherosclerotic plaques. Inflammatory proteins 
have been investigated in several studies as a 
biomarker of atherosclerosis. 
High sensitive C-reactive protein (hs-CRP) is 
one of the biomarkers that have been used 




widely.1-5 In patients with acute coronary 
syndrome (ACS), hs-CRP above 3 mg/l may be 
associated with a worse prognosis. However, 
some other studies have not confirmed the 
association between this biomarker and prognosis 
of the disease.6-13 
In addition, some studies have assessed the 
diagnostic value of this biomarker in diagnosis of 
ACSs including stable angina, unstable angina, 
and stroke; in some cases, it was proved as useful 
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contrary results.16,17 Hence, its efficiency is 
controversial, and there is a need for further 
researches. Differentiation of stable angina from 
unstable angina is important because they need 
different treatment procedures; however, there is 
a controversy about the efficiency of hs-CRP for 
differentiating stable from unstable angina.17-20 
Since some previous studies have shown that 
increased level of hs-CRP worsens the  
prognosis, 10,11,18,21 the assessment of diagnostic 
value of this biomarker for differentiating these two 
diseases can be clinically valuable because it can 
simultaneously indicate the prognosis of the disease. 
It is of great importance for clinicians to 
determine a cut-off point for diagnostic tests. 
Receiver operating characteristic (ROC) curve 
analysis is a method for determining the cut-off 
point. In this method, a curve is plotted for every 
point of diagnostic test valve to calculate 
sensitivity and specificity. Hence, this curve can 
present the diagnostic test’s efficiency for the 
classification of patients.22 
Therefore, this study aimed to examine the 
diagnostic value of hs-CRP levels and to determine 
the sensitivity and specificity of different levels of 
this biomarker in the differentiation of stable 
angina and unstable angina. 
Materials and Methods 
Using convenience sampling, patients with 
unstable angina were selected among those who 
referred to Tohid Hospital emergency in 
Sanandaj, Iran, due to chest pain, and patients 
with stable angina were selected among those 
referred to the special clinic in Tohid Hospital. 
Stable angina and unstable angina were 
confirmed by a cardiologist. 
This study was approved by the Ethics 
Committee of Kurdistan University of Medical 
Sciences and the purposes of the study were 
explained to patients and informed consents were 
obtained. Fasting blood samples were collected 
from all patients in the morning at the early time 
of attending the hospital. Exclusion criteria 
included the presence of infectious diseases in the 
past 3 weeks, the immune system and 
autoimmune disease, recent surgery in the past 2 
months, a history of trauma in the past 2 months, 
renal failure, liver failure, cancers, and the use of 
anti-inflammatory drugs. 
Considering differences between averages, 
having α = 1%, β = 10%, and average hs-CRP 
levels of 1.7 (± 0.9) mg/l for stable angina group 
versus 0.93 (± 0.9) mg/l for unstable angina group, 
the sample size was calculated to be 22 patients in 
each group;15 in this study, 30 patients were 
included in each group. All the patients filled a 
questionnaire which included their past records; in 
addition, to measure CRP, blood samples were 
tested using MONOBIND (Monobind, Inc. Lake 
Forest, CA, USA) laboratory kit, made in USA. 
Data were entered in SPSS for Windows 
(version 16.0, SPSS Inc., Chicago, IL, USA). The 
quantitative data in the two groups were 
compared using Student’s independent t-test or 
Mann-Whitney U test, and the qualitative data 
were compared using chi-square and Fisher exact 
test. To determine the CRP cut-off point, ROC 
curve was used, and the specificity and sensitivity 
were determined at the cut-off point. 
Results 
A total of 60 patients, including 30 patients with 
stable angina and 30 patients with unstable 
angina were studied. From all, 24 patients (40%) 
were female. Mean age of patients in the stable 
angina and unstable angina groups were  
62.1 ± 14.3 and 59.7 ± 12.9 years, respectively  
(P = 0.5). Among them, 16 (26.7%) patients were 
from rural areas and the rest were from urban 
areas. A total of 20 patients (33.3%) had a history 
of heart attack in their family. Twelve patients 
(20%) were smokers; 18 patients (30%) had a 
history of hypertension, 9 patients (15%) had a 
history of diabetes, and 17 patients (28%) had a 
history of hyperlipidemia. Apart from that blood 
pressure, which was higher in the unstable angina 
group (P = 0.024), the other variables were similar 
between the two groups and there was no 
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Table 1. Comparison of characteristics of patients in the two groups of unstable angina and stable angina 
Variables Stable angina Unstable angina P 
Sex    
Male, n (%) 19 (63.3) 17 (56.7) 0.790 
Female, n (%) 11 (36.7) 13 (43.3)  
Residency    
Urban, n (%) 20 (66.7) 24 (80.0) 0.380 
Rural, n (%) 10 (33.3) 6 (20.0)  
Family history of MI, n (%) 8 (26.7) 7 (23.3) 0.410 
Current smoker, n (%) 5 (16.7) 7 (23.3) 0.740 
Passive smoker, n (%) 7 (23.3) 6 (20.0) 0.754 
HTN, n (%) 5 (16.7) 13 (43.3) 0.024* 
Hyperlipidemia, n (%) 6 (20.0) 11 (36.7) 0.250 
Diabetes, n (%) 2 (6.7) 7 (23.3) 0.140** 
Age (year) 62.1 ± 14.3 59.7 ± 12.9 0.499*** 
BMI 26.4 ± 4.9 26.5 ± 3.5 0.991*** 
hs-CRP (mg/l) 1.6 ± 1.18 2.35 ± 1.3 0.025*,*** 
Smoking (pack/year) 5 (0.15-32) 19 (0.45-100) 0.268€ 
*
 Statistically significant;** Fisher’s exact test was applied; *** Independent t-test was applied; € Mann-Whitney U test was 
applied; Other comparisons were done by chi-square test; MI: Myocardial infection; HTN: Hypertension; BMI: Body mass 
index; hs-CRP: High sensitive C-reactive protein 
 
hs-CRP levels in patients with stable angina and 
unstable angina were 1.6 ± 1.18 and 2.35 ± 1.30 
mg/l, respectively, and the difference was 
statistically significant (P = 0.025). A hs-CRP  
level ≥ 2.31 mg/l was the best cut-off point for 
differentiating stable from unstable angina. In 
this cut-off point, the sensitivity and specificity 
were 56% and 73%, respectively (Figure 1). With 
a level of 2.31 mg/l, the area under the curve was 
calculated as 0.679 (95% confidence  
interval = 0.54-0.81) (P = 0.017). Table 2 shows 
sensitivity and specificity of some hs-CRP levels 
for differentiating stable and unstable angina. 
Discussion 
In this study, the baseline characteristics of the 
two groups were similar. Compared with stable 
angina group, hs-CRP level in patients with 
unstable angina was higher. The best cut-off 
point to differentiate unstable angina from stable 
angina was calculated as 2.31 mg/l. Therefore, 
hs-CRP seems to be helpful in differentiating 
stable angina from unstable angina. 
Differentiating stable from unstable angina is 
important because these two diseases need 
different processes and different approaches to be 
treated, and also there is no specific biomarker for 
differentiating these two. In this study, we 
concluded that to differentiate these two diseases 
we have to set a cut-off point. There are few 
studies that have assessed the diagnostic value of 















Figure 1. Receiver operating characteristic curve 
for differentiating unstable angina from stable 
angina; The area under the curve in a level of 2.31 
mg/l was calculated as 0.679 (95% confidence 
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Table 2. Calculated sensitivity and specificity of high 
sensitive C-reactive protein levels for the 
differentiation of stable angina from unstable angina 
hs-CRP (mg/l) Sensitivity Specificity 
0.130 1.00 0.03 
0.205 0.96 0.06 
0.265 0.96 0.13 
0.320 0.93 0.13 
0.450 0.93 0.16 
0.555 0.93 0.20 
0.615 0.93 0.26 
0.750 0.90 0.30 
0.815 0.86 0.30 
0.885 0.86 0.40 
0.970 0.83 0.43 
1.065 0.80 0.50 
1.220 0.70 0.50 
1.310 0.66 0.50 
1.420 0.60 0.50 
1.560 0.60 0.53 
1.740 0.60 0.56 
2.025 0.60 0.60 
2.250 0.56 0.66 
2.310† 0.56 0.73 
2.360 0.53 0.73 
2.415 0.53 0.76 
2.495 0.46 0.80 
2.615 0.43 0.80 
2.745 0.43 0.83 
2.860 0.43 0.86 
3.035 0.36 0.86 
3.235 0.30 0.90 
3.320 0.23 0.90 
3.545 0.20 0.93 
3.745 0.20 0.96 
3.940 0.16 0.96 
4.120 0.13 0.96 
4.250 0.10 0.96 
4.355 0.06 0.96 
4.445 0.03 0.96 
4.540 0.03 1.00 
5.560 0.00 1.00 
†
 The best diagnostic level; hs-CRP: High sensitive C-
reactive protein 
 
unstable angina. One of the studies showed that 
the best time for taking biomarker samples from 
patients with stable angina was in the morning, 
because the biomarker was at its highest level.21 
Based on the mentioned study, the biomarker’s 
level was associated with coronary artery disease 
and with increasing the severity of coronary 
artery disease the biomarker’s level was 
increased too. They determined a cut-off point for 
differentiating patients with severe coronary 
atherosclerosis based on the mild one which was 
equal to 5.5 mg/l in the morning with sensitivity 
and specificity of 66.4% and 79.1%, respectively.21 
In Thakur et al.’s study4 the hs-CRP levels in 
patients with coronary heart disease and in 
healthy subjects were reported as 1.70 ± 0.75 and 
0.93 ± 0.35 mg/l, respectively, which showed a 
statistically significant difference (P < 0.001). 
Some other studies also showed that patients 
with unstable angina which had higher levels of 
this biomarker were at higher risk of death and 
heart failure.13,18 
In the study by Diercks et al.,17 patients with 
chest pain were examined for ACS, and they 
were also tested to measure their levels of this 
biomarker. They concluded that this biomarker 
did not have a diagnostic value in differentiating 
the two groups. Even so, their study was 
retrospective and might have had some biases. 
Another study by Amanvermez et al.,20 showed 
that the hs-CRP level in patients with unstable 
angina was higher than in controls. They also 
concluded that this biomarker might be useful in 
early diagnosis of ACS. 
Our study had some limitations. We did not 
assess the relation between this biomarker and 
cardiac enzymes, electrocardiography changes, 
and the severity of coronary artery disease. 
Nonetheless, they were not among the objectives 
of the study, but assessing them could also 
present broader information about the 
biomarker in ACS. However, based on our 
results, the biomarker levels of 2.31 mg/l and 
higher show unstable angina while the levels 
below 2.31 mg/l indicate stable angina. When 
using this biomarker, the presence of infectious 
and inflammatory diseases should be considered 
because they will interfere with the test results. 
Conclusion 
hs-CRP level is valuable for differentiating patients 
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angina. It is recommended to consider the hs-CRP 
level of 2.31 mg/l as the best cut-off point. 
Conflict of Interests 
Authors have no conflict of interests. 
References 
1. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-
Anderson M, Savory J, et al. Evaluation of nine 
automated high-sensitivity C-reactive protein methods: 
implications for clinical and epidemiological 
applications. Part 2. Clin Chem 2001; 47(3): 418-25. 
2. Ridker PM. Clinical application of C-reactive protein 
for cardiovascular disease detection and prevention. 
Circulation 2003; 107(3): 363-9. 
3. Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, 
Tanizaki Y, et al. High-sensitivity C-reactive protein 
and coronary heart disease in a general population of 
Japanese: the Hisayama study. Arterioscler Thromb 
Vasc Biol 2008; 28(7): 1385-91. 
4. Thakur S, Gupta S, Parchwani H, Shah V, Yadav V. 
Hs-CRP-A Potential Marker for Coronary Heart 
Disease . Indian Journal of Fundamental and Applied 
Life Sciences 2011; 1(1): 1-4. 
5. Lind L. Circulating markers of inflammation and 
atherosclerosis. Atherosclerosis 2003; 169(2): 203-14. 
6. Libby P. Inflammation in atherosclerosis. Nature 2002; 
420(6917): 868-74. 
7. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, 
Stanek E. Variability and classification accuracy of 
serial high-sensitivity C-reactive protein measurements 
in healthy adults. Clin Chem 2001; 47(3): 444-50. 
8. Schaan BD, Pellanda LC, Maciel PT, Duarte ER, Portal 
VL. C-reactive protein in acute coronary syndrome: 
association with 3-year outcomes. Braz J Med Biol Res 
2009; 42(12): 1236-41. 
9. Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek 
HG, Murphy SA, et al. Relationship between  
C-reactive protein and subclinical atherosclerosis: the 
Dallas Heart Study. Circulation 2006; 113(1): 38-43. 
10. Zairis MN, Adamopoulou EN, Manousakis SJ, Lyras 
AG, Bibis GP, Ampartzidou OS, et al. The impact of hs 
C-reactive protein and other inflammatory biomarkers 
on long-term cardiovascular mortality in patients with 
acute coronary syndromes. Atherosclerosis 2007; 
194(2): 397-402. 
11. Zakynthinos E, Pappa N. Inflammatory biomarkers in 
coronary artery disease. J Cardiol 2009; 53(3): 317-33. 
12. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, 
Warnica JW, Domanski MJ, et al. Prognostic 
significance of the Centers for Disease 
Control/American Heart Association high-sensitivity 
C-reactive protein cut points for cardiovascular and 
other outcomes in patients with stable coronary artery 
disease. Circulation 2007; 115(12): 1528-36. 
13. Kazerani H, Rai AR. Correlation between serum high 
sensitivity CRP level and in hospital cardiac events in 
the patients with unstable angina. Sci J Hamdan Univ 
Med Sci 2007; 14(3): 5-9. [In Persian]. 
14. Madadi R, Haddadian K, Ghaderi E, Karimi K. 
Diagnostic value of high sensitivity C-reactive protein 
in differentiating unstable angina from myocardial 
infarction. Chron Dis J 2013; 1(1): 7-12. 
15. Zairis MN, Manousakis SJ, Stefanidis AS, Papadaki 
OA, Andrikopoulos GK, Olympios CD, et al. C-
reactive protein levels on admission are associated with 
response to thrombolysis and prognosis after ST-
segment elevation acute myocardial infarction. Am 
Heart J 2002; 144(5): 782-9. 
16. Yip HK, Hang CL, Fang CY, Hsieh YK, Yang CH, 
Hung WC, et al. Level of high-sensitivity C-reactive 
protein is predictive of 30-day outcomes in patients 
with acute myocardial infarction undergoing primary 
coronary intervention. Chest 2005; 127(3): 803-8. 
17. Diercks DB, Kirk JD, Naser S, Turnipseed S, 
Amsterdam EA. Value of high-sensitivity C-reactive 
protein in low risk chest pain observation unit patients. 
Int J Emerg Med 2011; 4: 37. 
18. Gharakhani M, Moradi M. A Survey on the Predictive 
Value of High-Sensitive C-Reactive Protein in Patients 
with Unstable Angina. Sci J Hamdan Univ Med Sci 
2012; 19(2): 23-7. [In Persian]. 
19. Basak SK, Akhtaruzzaman KM, Kundu AK, Ranjan 
Dey S, Uddin F. Prognostic value of high-sensitivity  
C-reactive protein in Acute ST-segment elevation 
myocardial infarction in hospitalized patients. Medicine 
Today 2012; 24(1): 36-9. 
20. Amanvermez R, Acar E, Gunay M, Baydin A, Yardan 
T, Bek Y. Hsp 70, hsCRP and oxidative stress in 
patients with acute coronary syndromes. Bosn J Basic 
Med Sci 2012; 12(2): 102-7. 
21. Koc M, Karaarslan O, Abali G, Kemal Batur M. 
Variation in high-sensitivity C-reactive protein levels 
over 24 hours in patients with stable coronary artery 
disease. Tex Heart Inst J 2010; 37(1): 42-8. 
22. Obuchowski NA. Receiver operating characteristic 
curves and their use in radiology. Radiology 2003; 
229(1): 3-8. 
 
